A model with separate hepato-portal compartment ("first-pass" model): fitting to plasma concentration-time profiles in humans.
OBJECTIVE
To demonstrate the value of "first-pass" pharmacokinetic models (FPMs) in which the hepato-portal (HP) system is kinetically separated from the central compartment in fitting pharmacokinetic data obtained after intravenous (IV) and oral administration.


METHODS
Plasma concentration-time profiles of an investigational drug obtained in six healthy subjects each received 4 mg as an intravenous (IV) bolus dose and 10 mg as an oral solution served as a real data example. The common three- and four-compartment models with the first-order absorption and lag time (3CM and 4CM, respectively) in which HP system is assumed to be part of the central compartment were used as alternative models. We tested also: (i) the sensitivity of the output of FPM to variations in its parameters assuming IV and oral administration; (ii) practical estimability of the FPM parameters by fitting it to 20 simulated noisy data sets; (iii) distinguishability of FPM, 3CM and 4CM by fitting them to the simulated data sets.


RESULTS
FPM was shown to give the best fit as compared to 3CM or 4CM in 5 subjects of 6. The sensitivity of FPM was sufficient for the sake of parameter estimation. The "individual" means of parameter estimates obtained after fitting simulated data did not differ significantly from the preselected values. The variance in "individual" estimates was dependent on the sampling frequency. FPM was demonstrated to be distinguishable among relevant models.


CONCLUSIONS
FPM is preferable as compared to standard compartmental models for drugs extensively taken up by the intestine and/or the liver, and may have a broad spectrum of applications.
Piotrovskij
V
V
Janssen Research Foundation, Department of Clinical Pharmacokinetics, Beerse, Belgium. vpiotrov@janbe.jnj.com
Van Peer
A
A
D000284:Administration, Oral; D000328:Adult; D006801:Humans; D007275:Injections, Intravenous; D008099:Liver / Q000378:metabolism*; D008297:Male; D008954:Models, Biological; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D010599:Pharmacokinetics; D011168:Portal System / Q000378:metabolism; D012680:Sensitivity and Specificity
D004364:Pharmaceutical Preparations